Westlake BioPartners GP I, LLC insider trades: Kyverna Therapeutics (KYTX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Westlake BioPartners GP I, LLC reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | KYTX | ↑ Buy | 133,333 | $7.50 | $1000K | Indirect | Dec 22, 2025 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KYTX insiders
Open-market trades in the last 12 months
About Westlake BioPartners GP I, LLC's insider trades
Westlake BioPartners GP I, LLC is a 10% owner of Kyverna Therapeutics (KYTX). Since Dec 18, 2025, it has reported 1 open-market purchase worth $1000K and no sales on SEC Form 4. In the last 12 months: 1 buy ($1000K).
Its filings also include conversions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KYTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.